Preoperative tumour biopsy does not affect the oncologic course of patients with transplantable HCC

Journal of Hepatology

Volumn 61, Issue 3, 2014, Pages 589-593

  Fuks, David ^a   Cauchy, Francois ^a   Fusco, Grazia ^a   Paradis, Valerie ^a   Durand, Francois ^a   Belghiti, Jacques ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

HCC; Liver biopsy; Liver transplantation; Tumour recurrence

Indexed keywords

ADULT; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; DEMOGRAPHY; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; INTENTION TO TREAT ANALYSIS; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT DROPOUTS; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; TUMOR BIOPSY; ADVERSE EFFECTS; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; COMPARATIVE STUDY; INCIDENCE; KAPLAN MEIER METHOD; LIVER; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PREOPERATIVE CARE; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; BIOPSY, FINE-NEEDLE; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; LIVER; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84906323708     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.04.046     Document Type: Article

References (18)

1. P.A. Clavien, M. Lesurtel, P.M. Bossuyt, G.J. Gores, B. Langer, and A. Perrier et al. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report Lancet Oncol 13 2012 e11 e22
2. J.M. Llovet, A. Burroughs, and J. Bruix Hepatocellular carcinoma Lancet 362 2003 1907 1917
3. J. Bruix, and M. Sherman Practice guidelines committee, american association for the study of liver diseases. Management of hepatocellular carcinoma Hepatology 42 2005 1208 1236
4. P. Compagnon, S. Grandadam, R. Lorho, B. Turlin, C. Camus, and Y. Jianrong et al. Liver transplantation for hepatocellular carcinoma without preoperative tumour biopsy Transplantation 86 2008 1068 1076
5. H. Kim, G.H. Choi, D.C. Na, E.Y. Ahn, G.I. Kim, and J.E. Lee et al. Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis Hepatology 54 2011 1707 1717
6. F. Durand, J.M. Regimbeau, J. Belghiti, A. Sauvanet, V. Vilgrain, and B. Terris et al. Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma J Hepatol 35 2001 254 258
7. M.A. Silva, B. Hegab, C. Hyde, B. Guo, J.A. Buckels, and D.F. Mirza Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis Gut 57 2008 1592 1596
8. R. Stigliano, L. Marelli, D. Yu, N. Davies, D. Patch, and A.K. Burroughs Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC Cancer Treat Rev 33 2007 437 447
9. A.W. Hemming, M.S. Cattral, A.I. Reed, W.J. Van Der Werf, P.D. Greig, and R.J. Howard Liver transplantation for hepatocellular carcinoma Ann Surg 233 2001 652 659
10. R. Stigliano, and A.K. Burroughs Should we biopsy each liver mass suspicious for HCC before liver transplantation? - No, please don't J Hepatol 43 2005 563 568
11. B. Roche, and D. Samuel Liver transplantation in viral hepatitis: prevention of recurrence Best Pract Res Clin Gastroenterol 22 2008 1153 1169
12. D. Fuks, S. Dokmak, V. Paradis, M. Diouf, F. Durand, and J. Belghiti Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis Hepatology 55 2012 132 140
13. F. Durand, J. Belghiti, and V. Paradis Liver transplantation for hepatocellular carcinoma: role of biopsy Liver Transpl 13 2007 S17 S23
14. I.T. Gilmore, A. Burroughs, I.M. Murray-Lyon, R. Williams, D. Jenkins, and A. Hopkins Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London Gut 36 1995 437 441
15. P. Sharma, K. Welch, H. Hussain, S.J. Pelletier, R.J. Fontana, and J. Marrero et al. Incidence and risk factors of hepatocellular carcinoma recurrence after liver transplantation in the MELD era Dig Dis Sci 57 2012 806 812
16. V. Mazzaferro, J.M. Llovet, R. Miceli, S. Bhoori, M. Schiavo, and L. Mariani et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis Lancet Oncol 10 2009 35 43
17. M. Lesurtel, D.A. Raptis, E. Melloul, A. Schlegel, C. Oberkofler, and A.M. El-Badry et al. Low platelet counts after liver transplantation predict early post-transplant survival: the "60-5 criterion" Liver Transpl 20 2013 147 155
18. M. Rodríguez-Perálvarez, T.V. Luong, L. Andreana, T. Meyer, A.P. Dhillon, and A.K. Burroughs A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability Ann Surg Oncol 20 2013 325 339